Live prices from 66 UK suppliers, from £10.95, compared side by side so you never overpay.
Copy the code — you'll paste it at checkout.
with our exclusive code
You're about to visit an external supplier
with our exclusive code
By clicking "Continue", you acknowledge that you understand and accept the above. Read our full disclosure.
Compare 1 price for Semaglutide. Cheapest: £49.00. Average: £49.00.
| Compare | Visit | |||||||
|---|---|---|---|---|---|---|---|---|
| £49.00 | £49.00/mg | In Stock | Free |
—
|
— | Unavailable |
More ways to compare Semaglutide
Different views of the same live UK pricing, tuned for how you like to shop.
Compare another peptide
All purchases are made directly from third-party suppliers; your relationship is solely with them. We accept no liability for the quality, purity, or legality of any products listed.
We may earn a commission when you click through to a supplier and make a purchase. This does not affect pricing information displayed.
By using this site you accept responsibility for ensuring purchases comply with applicable laws in your jurisdiction. Read our full disclosure.
GLP-1 Receptor Agonist | Weight Loss & Diabetes
Long-acting GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management. Over 17,000 trial participants have demonstrated significant efficacy through appetite suppression and glycemic control. The 7-day half-life enables convenient weekly dosing.
Mimics native GLP-1, binding to receptors to stimulate glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite via hypothalamic pathways.
HUEGTFTSDVSSYLEGQAAKEFIAWLVRGRG
Histidine
Position 1
Aminoisobutyric Acid
Position 2
Glutamic Acid
Position 3
Glycine
Position 4
Threonine
Position 5
Phenylalanine
Position 6
Threonine
Position 7
Serine
Position 8
Aspartic Acid
Position 9
Valine
Position 10
Serine
Position 11
Serine
Position 12
Tyrosine
Position 13
Leucine
Position 14
Glutamic Acid
Position 15
Glycine
Position 16
Glutamine
Position 17
Alanine
Position 18
Alanine
Position 19
Lysine
Position 20
Glutamic Acid
Position 21
Phenylalanine
Position 22
Isoleucine
Position 23
Alanine
Position 24
Tryptophan
Position 25
Leucine
Position 26
Valine
Position 27
Arginine
Position 28
Glycine
Position 29
Arginine
Position 30
Glycine
Position 31
FDA-approved for chronic weight management with average 15-20% body weight loss in clinical trials.
Reduces hunger and food cravings through central nervous system GLP-1 receptor activation.
Long-term studies show maintained weight loss with continued treatment over 2+ years.
FDA-approved for type 2 diabetes with HbA1c reductions of 1.5-2% in clinical trials.
Proven 26% reduction in cardiovascular death, MI, or stroke in high-risk diabetes patients.
Improves insulin secretion and may preserve pancreatic beta cell function.
Addresses multiple components: weight, glucose, blood pressure, and lipids.
Emerging evidence for improvements in non-alcoholic fatty liver disease.
Decreases systemic inflammation markers independent of weight loss.
Pre-filled pen devices for once-weekly subcutaneous injection. Brands include Ozempic (diabetes) and Wegovy (weight loss).
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Weight Loss Initiation | 0.25mg | Weekly x 4 weeks, then increase | Subcutaneous |
| Weight Loss Maintenance | 2.4mg | Weekly (after 16-week titration) | Subcutaneous |
| Diabetes Management | 0.5-1mg | Weekly | Subcutaneous |
| Cardiovascular Protection | 0.5-1mg | Weekly | Subcutaneous |
| Tolerability-Based | 0.25-2.4mg | Weekly (individualized) | Subcutaneous |
Rybelsus tablets use SNAC technology for enhanced absorption. Requires strict administration protocol.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Diabetes Initiation | 3mg | Daily x 30 days | Oral (empty stomach) |
| Standard Diabetes Dose | 7mg | Once daily | Oral (empty stomach) |
| Maximum Diabetes Dose | 14mg | Once daily | Oral (empty stomach) |
May increase hypoglycemia risk when combined; requires blood glucose monitoring.
Both are incretin mimetics with overlapping mechanisms; concurrent use increases side effects.
Combined as CagriSema in clinical trials for enhanced weight loss efficacy.
Commonly used together for diabetes management with good safety profile.
No contraindications; may help with GI side effects.
Increased hypoglycemia risk; may require sulfonylurea dose reduction.
Delayed gastric emptying may affect absorption of oral medications.
Mild appetite reduction, possible nausea during initial dose
Noticeable weight loss (5-10% typical), improved satiety
Continued weight loss (10-15% common), stable glucose levels
Weight loss plateau possible, focus on maintenance
Blood sugar improvements within 1-2 weeks
14.9% average weight loss versus 2.4% with placebo over 68 weeks with 2.4mg weekly.
20% reduction in major adverse cardiovascular events over 5 years with 2.4mg weekly.
Average HbA1c reductions of 1.5-1.8% across multiple trials.
Sustained weight loss of 15.2% at week 104 with 2.4mg weekly.
Oral efficacy comparable to injectable formulations at 3-14mg daily.
16.1% BMI reduction in adolescent population over 68 weeks.
Plain-English guides and study summaries from published literature.
Guides
7 min
Most guys hear “GLP-1” and immediately land in one of two camps: Camp 1: “It’s a miracle drug that melts fat with zero downside.” Camp 2: “It’ll destroy your body—lose muscle, wreck your metabolism, end up frail.”
Read article
Guides
6 min
Semaglutide works because it makes a calorie deficit easier to sustain. It suppresses appetite, slows gastric emptying, and helps you feel full longer. But it doesn’t burn fat directly, it can come with a real lean-mass loss problem, and a lot of people regain weight after stopping unless they use that appetite-suppression window to build habits. And if your real goal is fat loss and body composition, there are newer options that generally perform better.
Read articleBe the first to know when prices drop on your favourite peptides
No spam. Unsubscribe anytime. We respect your privacy.